Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen (Q44899131)

7 December 2017

title

Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen (English)

1 reference

7 December 2017

Katrin S Reiners

1

1 reference

7 December 2017

Hinrich P Hansen

2

1 reference

7 December 2017

Anne Krüssmann

3

1 reference

7 December 2017

Gisela Schön

4

1 reference

7 December 2017

Elena Csernok

5

1 reference

7 December 2017

Wolfgang L Gross

6

1 reference

7 December 2017

Andreas Engert

7

1 reference

7 December 2017

Elke Pogge Von Strandmann

8

1 reference

7 December 2017

publication date

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

112

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

228-236

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

7 December 2017

1 reference

Wegener Granulomatosis: An Analysis of 158 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

The Pathogenic Role of Antineutrophil Cytoplasmic Autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Immunotoxins against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Immunotoxins in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

The emerging role of immunotoxins in leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Cloning and cytotoxicity of a human pancreatic RNase immunofusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01875.X

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Rare diseases.3: Wegener's granulomatosis

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Monocyte activation in patients with Wegener's granulomatosis

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Effects of cyclophosphamide on the development of malignancy and on long‐term survival of patients with rheumatoid arthritis a 20‐year followup study

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Cyclophosphamide-induced bladder toxicity in wegener's granulomatosis

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Antibodies against granule proteins activate neutrophils in vitro

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Humanization of immunotoxins

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782481

Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre

27 August 2018

1 reference

12 December 2020

Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides

1 reference

12 December 2020

Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo

1 reference

12 December 2020

Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis

1 reference

12 December 2020

ANCA and predicting relapse in systemic vasculitis

1 reference

12 December 2020

Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies

1 reference

12 December 2020

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study

1 reference

12 December 2020

Immunotoxins: magic bullets or misguided missiles?

1 reference

12 December 2020

Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules

1 reference

12 December 2020

10.1111/J.1365-2567.2004.01875.X

Identifiers

DOI

1 reference

7 December 2017

0 references

1 reference